Eyevensys Appoints Dr Ronald R. Buggage as Chief Medical Officer

PARIS, September 4, 2017 /PRNewswire/ --
Eyevensys, a clinical stage biotech company developing its proprietary EyeCET platform, the first non-viral gene expression technology that enables the safe, local, sustained production of therapeutic proteins in the eye to address a wide range...